Cargando…
Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients
BACKGROUND: Colon adenocarcinoma (COAD) is a highly heterogeneous disease, thus making prognostic predictions uniquely challenging. Metabolic reprogramming is emerging as a novel cancer hallmark that may serve as the basis for more effective prognosis strategies. METHODS: The mRNA expression profile...
Autores principales: | Zheng, Yang, Wu, Rilige, Wang, Ximo, Yin, Chengliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021388/ https://www.ncbi.nlm.nih.gov/pubmed/35462848 http://dx.doi.org/10.3389/fpubh.2022.860381 |
Ejemplares similares
-
Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
por: Yao, Yan, et al.
Publicado: (2021) -
A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes
por: Ren, Yangzi, et al.
Publicado: (2022) -
The Construction and Development of a Clinical Prediction Model to Assess Lymph Node Metastases in Osteosarcoma
por: Li, Wenle, et al.
Publicado: (2022) -
Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma
por: Yang, Mian, et al.
Publicado: (2022) -
Identification and Development of a 4-Gene Ferroptosis Signature
Predicting Overall Survival for Diffuse Large B-Cell Lymphoma
por: Wu, Huitao, et al.
Publicado: (2023)